E-Cadherin (CDH1) Protein

E-Cadherin (CDH1) Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">E-Cadherin (CDH1) Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CDH1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>E-Cadherin (CDH1)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=CDH1" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/ataxia" style="color:#ef9a9a">Ataxia</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">398 edges</a></td>
</tr>
</table>

Pathway Diagram

E-Cadherin (CDH1) Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">E-Cadherin (CDH1) Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CDH1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>E-Cadherin (CDH1)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=CDH1" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/ataxia" style="color:#ef9a9a">Ataxia</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">398 edges</a></td>
</tr>
</table>

Pathway Diagram

Overview

CDH1 (encodes E-cadherin) is a classical type I cadherin that mediates calcium-dependent homophilic cell-cell adhesion. As a transmembrane glycoprotein, E-cadherin is essential for maintaining tissue architecture and cellular polarity. In the nervous system, E-cadherin plays critical roles in synaptic formation, plasticity, and neuronal migration. Emerging research demonstrates that CDH1 dysfunction contributes to neurodegenerative disease pathogenesis through multiple mechanisms including synaptic integrity disruption, altered Wnt signaling, and impaired cell-cell communication.

E-cadherin is a tumor suppressor frequently lost in carcinomas, paradoxically promoting metastasis in advanced cancers. In the brain, its expression in neurons and glia makes it a key regulator of neural circuit formation and function. The cadherin-catenin complex at synaptic junctions represents a critical hub for trans-synaptic signaling and structural maintenance.

Structure and Biochemistry

Protein Architecture

E-cadherin is a type I transmembrane glycoprotein composed of distinct functional domains:

• Extracellular Domain (residues 1-707): Contains five tandem cadherin repeats (EC1-EC5), each approximately 110 amino acids. The EC1 domain mediates homophilic binding specificity. Calcium ions bind between adjacent repeats, stabilizing the ectodomain in a rigid, rod-like conformation essential for adhesion. Each repeat contains conserved DXNDN and DXD motifs coordinating calcium.
• Transmembrane Domain (residues 708-738): A single-pass helical anchor that positions the extracellular and intracellular domains on opposite sides of the plasma membrane.
• Cytoplasmic Domain (residues 739-882): The intracellular region comprises three conserved regions:
• Catenin-binding domain (CBD): Residues 760-820, binds β-catenin and p120-catenin
• p120-catenin binding site: Overlaps with CBD, can bind p120-catenin independently
• α-catenin binding region: Interfaces with α-catenin for actin linkage

Molecular Interactions

E-cadherin forms both cis-dimers (between molecules on the same cell) and trans-dimers (between molecules on adjacent cells). The trans interaction involves insertion of a tryptophan residue from the EC1 domain into a hydrophobic pocket on the partner molecule. This "strand-swap" dimerization is the fundamental basis of cadherin-mediated adhesion.

The cytoplasmic domain recruits multiple catenin proteins:

• β-catenin: Binds directly to the CBD, links to α-catenin and the actin cytoskeleton
• p120-catenin: Binds the juxtamembrane domain, stabilizes cadherin at the plasma membrane and prevents endocytosis
• α-catenin: Connects the complex to the actin cytoskeleton, enabling force transmission

Normal Physiological Functions

Epithelial Tissue Maintenance

In epithelial tissues, E-cadherin forms the core of adherens junctions, creating continuous adhesion belts around cells. This organizes the actin cytoskeleton, maintains epithelial polarity, and establishes contact inhibition of proliferation. The tight regulation of E-cadherin-mediated adhesion is essential for tissue homeostasis.

Synaptic Function and Plasticity

In the nervous system, E-cadherin is prominently expressed at synaptic junctions, particularly in dendritic spines and presynaptic terminals. Key functions include:

• Synaptic Assembly: During development, E-cadherin-mediated adhesion initiates synapse formation. The cadherin-catenin complex clusters at nascent synaptic contacts, recruiting additional synaptic proteins.
• Spine Morphogenesis: E-cadherin regulates dendritic spine shape and stability. The dynamic regulation of spine E-cadherin allows structural plasticity essential for learning and memory.
• Synaptic Transmission: The cadherin-catenin complex interacts with neurotransmitter receptors and signaling molecules, modulating synaptic strength and plasticity.
• Synaptic Junctional Complexity: At excitatory synapses, E-cadherin colocalizes with postsynaptic density proteins and contributes to the organization of the postsynaptic density.

Neuronal Development

E-cadherin plays essential roles in early neural development:

• Neural Tube Formation: Cell-cell adhesion via E-cadherin is required for the epithelial-to-mesenchymal transition during neural tube closure.
• Neuronal Migration: During cortical development, E-cadherin-mediated adhesion guides migrating neurons along radial glial cells.
• Axon Guidance: Growth cones express E-cadherin and respond to guidance cues that alter cadherin-mediated adhesion.
• Dendrite Arborization: E-cadherin regulates the branching pattern of dendritic arbors through dynamic adhesion sites.

Wnt Signaling Regulation

E-cadherin sequesters β-catenin at the plasma membrane, preventing its nuclear translocation and transcriptional activity. This serves two purposes:

• Limits β-catenin-driven proliferation in epithelia
• Modulates Wnt target gene expression in neurons, affecting differentiation and plasticity

Role in Alzheimer's Disease

Synaptic Dysfunction

Alzheimer's disease (AD) is characterized by early synaptic loss that correlates with cognitive decline. E-cadherin dysfunction emerges as a significant contributor to synaptic pathology:

Amyloid-β Effects: Amyloid-β oligomers directly disrupt E-cadherin-mediated adhesion. Studies demonstrate that Aβ42 oligomers bind to the extracellular domain of E-cadherin, interfering with trans-dimer formation and weakening synaptic junctions. This disruption occurs before significant synapse loss, suggesting a causative role[@cadherin_amyloid_2020].

Cadherin-Catenin Complex Alteration: Post-mortem AD brain tissue shows reduced E-cadherin and β-catenin at synaptic membranes. The dissociation of the cadherin-catenin complex contributes to:

• Impaired spine stability
• Reduced synaptic plasticity
• Altered NMDA receptor signaling

Tau Pathology Interaction

The microtubule-associated protein tau pathologies in AD may interact with E-cadherin function:

• Hyperphosphorylated tau accumulates at synapses and may disrupt the cadherin-catenin complex
• Tau pathology correlates with loss of synaptic E-cadherin clusters
• The interplay between tau and cadherin dysfunction accelerates synaptic degeneration

Beta-Catenin Signaling Dysregulation

β-catenin accumulation in AD brains reflects both E-cadherin loss and altered Wnt signaling:

• Reduced E-cadherin releases β-catenin into the cytoplasm
• Nuclear β-catenin accumulation may trigger aberrant gene expression
• Dysregulated Wnt/β-catenin signaling contributes to neuronal dysfunction

Therapeutic Implications

E-cadherin represents a potential therapeutic target in AD:

• Stabilizing Synaptic Adhesion: Small molecules that stabilize E-cadherin trans-dimers could preserve synaptic integrity
• Inhibiting Amyloid Binding: Compounds blocking Aβ binding to E-cadherin may protect synaptic junctions
• Restoring Beta-Catenin Balance: Modulating β-catenin signaling could normalize downstream effects

Role in Parkinson's Disease

Dopaminergic Neuron Vulnerability

Parkinson's disease (PD) involves selective loss of dopaminergic neurons in the substantia nigra pars compacta. E-cadherin expression in these neurons relates to their vulnerability:

• Substantia nigra dopaminergic neurons express lower E-cadherin than nearby ventral tegmental area neurons
• This lower expression correlates with greater vulnerability to neurodegeneration
• E-cadherin expression patterns may explain regional selectivity in PD

Lewy Body Pathology

Lewy bodies, the characteristic protein inclusions in PD, contain cell adhesion molecules:

• E-cadherin is found in Lewy body inclusions
• The disruption of cadherin-mediated adhesion may precede α-synuclein aggregation
• Altered cell adhesion could contribute to the spread of α-synuclein pathology

Mitochondrial Function

E-cadherin signaling influences mitochondrial dynamics in neurons:

• Cadherin engagement activates signaling pathways affecting mitochondrial fission/fusion
• Loss of E-cadherin disrupts mitochondrial homeostasis
• Mitochondrial dysfunction in PD may be exacerbated by cadherin dysfunction

Role in Other Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

E-cadherin alterations appear in ALS:

• Motor neurons show reduced E-cadherin expression
• Disrupted cell adhesion contributes to motor neuron vulnerability
• The cadherin-catenin complex interacts with ALS-linked proteins

Frontotemporal Dementia

• Altered E-cadherin expression in frontal cortex
• Cadherin dysfunction contributes to synaptic loss
• May interact with tau pathology

Multiple Sclerosis

While primarily demyelinating, MS involves neuronal dysfunction:

• E-cadherin alterations at the blood-brain barrier
• Implicated in leukocyte transmigration
• Contributes to neurovascular unit dysfunction

Epigenetic Regulation

CDH1 expression is epigenetically regulated:

• DNA methylation of the CDH1 promoter reduces expression
• Histone modifications affect CDH1 transcription
• Epigenetic alterations in neurodegeneration may silence CDH1

Interplay with Other Cell Adhesion Molecules

E-cadherin interacts with other synaptic adhesion systems:

• N-cadherin: Competes with E-cadherin for catenin binding
• Neuroligin/Neurexin: Cooperates with cadherins in synapse organization
• Integrins: Coordinated signaling in synaptic adhesion

Blood-Brain Barrier Function

E-cadherin is a key component of the neurovascular unit:

• Maintains endothelial tight junction integrity
• Regulates blood-brain barrier permeability
• Dysfunction contributes to barrier breakdown in neurodegeneration

Exosomal Communication

E-cadherin is released in neuronal exosomes:

• Exosomal E-cadherin may serve as a signaling molecule
• Altered exosomal E-cadherin in neurodegenerative diseases
• Potential biomarker utility

Autophagy and Turnover

E-cadherin turnover is regulated by autophagy:

• Selective autophagy targets E-cadherin for degradation
• Impaired autophagy in neurodegeneration affects cadherin homeostasis
• Restoring autophagy could normalize E-cadherin levels

Therapeutic Strategies

Small Molecule Approaches

• Cadherin Stabilizers: Compounds enhancing trans-dimer formation
• Beta-Catenin Modulators: Normalizing β-catenin signaling
• Amyloid-Cadherin Blockers: Preventing Aβ binding to E-cadherin

Gene Therapy

• Viral vector-mediated CDH1 expression
• CRISPR-based approaches for CDH1 regulation
• siRNA targeting CDH1 downregulation

Protein-Based Therapeutics

• Recombinant E-cadherin ectodomain proteins
• Cadherin-catenin complex stabilizers
• Peptide mimics of functional domains

Research Directions

Model Systems

• Human iPSC-derived neurons
• Organoid models of synaptic development
• In vivo imaging of synaptic cadherin dynamics

Biomarker Potential

• Exosomal E-cadherin as a fluid biomarker
• CSF E-cadherin measurement
• Imaging of synaptic cadherin integrity

Genetic Studies

• CDH1 polymorphisms and neurodegeneration risk
• Gene-environment interactions
• CDH1 expression quantitative trait loci

Summary

E-cadherin (CDH1) is a critical cell adhesion molecule with essential roles in synaptic function and neuronal development. In neurodegenerative diseases including Alzheimer's and Parkinson's, E-cadherin dysfunction contributes to synaptic loss, altered signaling, and neuronal vulnerability. The cadherin-catenin complex represents a therapeutic target for preserving synaptic integrity and potentially slowing disease progression. Understanding the precise mechanisms of E-cadherin dysfunction may yield novel interventions for these devastating disorders.

See Also

• [Amyloid-beta](/mechanisms/amyloid-cascade)
• [Synaptic plasticity](/mechanisms/synaptic-plasticity)
• [Beta-catenin signaling](/mechanisms/wnt-signaling)
• [Alzheimer's disease](/diseases/alzheimers-disease)
• [Parkinson's disease](/diseases/parkinsons-disease)
• [Cell adhesion molecules](/entities/cadherins)

External Links

• [UniProt: P12830 (CDH1 Human)](https://www.uniprot.org/uniprot/P12830)
• [NCBI Gene: 999](https://www.ncbi.nlm.nih.gov/gene/999)
• [Human Protein Atlas: CDH1](https://www.proteinatlas.org/gene/CDH1)